SCHEMBL7725703

SCHEMBL7725703

CC(C)(C)OC(=O)NCC(=O)NC1C[C@@H](C(=O)Nc2ccc(C(C)(C)C)cc2)N(C(=O)OC(C)(C)C)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C19 P33261 1/20 0.43
NPC1 O15118 1/20 0.43
HDAC8 Q9BY41 6/20 0.41
HSD11B1 P28845 1/20 0.41
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
PTPN2 P17706 1/20 0.38
PTPN1 P18031 1/20 0.38
PTPN6 P29350 1/20 0.38
ABL1 P00519 2/20 0.37
BCR P11274 2/20 0.37
PABPC1 P11940 1/20 0.36
F13A1 P00488 1/20 0.36
TGM2 P21980 1/20 0.36
TGM1 P22735 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7728188 0.91 POLB (0.47) POLBCYP1A2CYP3A4CYP2C19NPC1
SCHEMBL7731723 0.89 HDAC8 (0.44) POLBCYP1A2CYP3A4CYP2C19NPC1
SCHEMBL7726519 0.88 POLB (0.42) POLBCYP1A2CYP3A4CYP2C19NPC1
SCHEMBL7731475 0.88 HDAC8 (0.44) POLBCYP1A2CYP3A4CYP2C19NPC1
SCHEMBL7727250 0.85 LTA4H (0.45) POLBNPC1HDAC8LMNA
SCHEMBL7728411 0.84 MEN1 (0.39) POLBCYP1A2CYP3A4CYP2C19NPC1
SCHEMBL7728407 0.84 MEN1 (0.39) POLBCYP1A2CYP3A4CYP2C19NPC1
SCHEMBL7722104 0.83 PABPC1 (0.45) POLBCYP1A2CYP3A4CYP2C19HDAC8
SCHEMBL7729234 0.81 HDAC4 (0.44) POLBCYP1A2CYP3A4CYP2C19HDAC8
SCHEMBL7726834 0.80 BTK (0.40) POLBCYP1A2CYP3A4CYP2C19HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed